Budesonide & formoterol is a combination medication that is often used for the management of diseases affecting the airway. Budesonide is a corticosteroid that suppresses airway inflammation, while formoterol is a long-acting beta-2 agonist (LABA) that relaxes and widens the bronchial tubes to improve airflow. Together, they provide both anti-inflammatory and bronchodilatory effects, providing relief for people suffering from asthma and COPD.

Budesonide + Formoterol contains a fixed-dose combination medication, budesonide & formoterol, both of which target two specific problems of the airway: inflammation and bronchoconstriction (narrowing of the airway). Combining both actions in a single inhaler simplifies treatment as the person does not require two separate inhalers.

Budesonide belongs to the corticosteroid family and suppresses the immune cells and inflammatory signals, which can otherwise result in airway swelling and mucus production. On the contrary, formoterol acts on beta-2 receptors present in the smooth muscles of the airway, causing them to relax. This dual action helps reduce the frequency and severity of asthma attacks and COPD flare-ups if the medicine is taken regularly.

This combination is often recommended to patients whose condition does not improve with an inhaled corticosteroid alone. It is not a quick-relief medicine for sudden asthma attacks or COPD flare-ups, but rather a maintenance medication. Sudden discontinuation of Budesonide + Formoterol after prolonged use should be avoided. Further, those switching from systemic steroids to budesonide should be monitored carefully for adrenal insufficiency. Adrenal insufficiency is a serious disorder where the adrenal glands (located on top of each kidney) stop producing enough cortisol (a steroid hormone), resulting in chronic fatigue, muscle weakness, weight loss and low blood pressure.

The combination of Budesonide & Formoterol is prescribed by doctors for the following conditions:

Asthma

Use of this combination can help maintain and prevent asthma symptoms such as wheezing, breathlessness, tightness in the chest, and coughing, in both children and adults.

Chronic obstructive pulmonary disease (COPD)

Long-term use of Budesonide + Formoterol can help improve airflow, reduce breathlessness, and decrease the frequency of COPD exacerbations in adults. It can be used for the management of both chronic bronchitis and emphysema

The combination of Budesonide & Formoterol in Budesonide + Formoterol provides a dual-action approach to manage the airway diseases:

• Simplifies treatment by combining two properties (anti-inflammatory and bronchodilatory) in a single inhaler.

• Lowers the frequency and severity of asthma attacks by reducing airway inflammation.

• Bronchodilation (relaxation of the airways) from formoterol begins within minutes and lasts up to 12 hours

• Reduces the number of COPD flare-ups

• Improves lung function, which is often measured by measurements such as FEV1 (forced expiratory volume) and peak expiratory flow

• Reduces dependence on short-acting rescue inhalers when used consistently as a maintenance medicine

Common side effects of Budesonide + Formoterol may include

• Oral candidiasis (fungal infection in the mouth and throat) with inhaled forms

• Hoarseness or voice changes with inhalers

• Nausea, stomach discomfort, or bloating; seen with oral capsules

• Headache

• Cough

• Tremor (involuntary shaking)

• Nasal dryness or irritation; seen with nasal spray

• Palpitations (sudden pounding or racing of the heart)

• Mild upper respiratory infections

Uncommon side effects of Budesonide + Formoterol may include

• Increased heart rate (tachycardia)

• Mild increase in blood pressure

• Low potassium levels in blood (hypokalemia)

• Bruising or thinning of skin, seen in people with prolonged use

• Increase in blood glucose levels

• Sleep disturbances & restlessness

• Slower growth rate in children on long-term therapy

• Pneumonia could be seen in people with COPD

Serious side effects that may require immediate medical attention include

• Paradoxical bronchospasm, sudden worsening of breathing after using the inhaler due to constriction of the airway

• Severe adrenal insufficiency, usually seen when people switch from systemic steroids

• Cushing's syndrome features, which include moon face, weight gain and purple coloured stretch marks, are seen with prolonged high doses

• Severe infections, such as TB (tuberculosis), pneumonia, or fungal infections, due to immune suppression

• increased intraocular pressure (pressure inside the eye) or glaucoma (an eye disease that can result in permanent vision loss)

• Angioedema, a severe allergic reaction that can cause swelling of the face, mouth, tongue and throat

• Severe cardiovascular side effects such as chest pain, fast or irregular heartbeat, and extremely high blood pressure

Budesonide + Formoterol can be used in the following ways:

• Metered-dose inhaler (MDI): Shake well, exhale fully, seal your lips around the mouthpiece, inhale deeply, hold breath for 10 seconds. Always rinse your mouth with water and spit after each use to prevent oral fungal infection.

• Nebuliser solution: Use only with the nebuliser recommended by your doctor. Do not mix with other medicines in the nebuliser unless advised. Follow your doctor's instructions on dose, frequency, and duration of nebulisation.

It is advised to take the inhaler at the same time each day to maintain consistent levels of the medicine. This is a maintenance inhaler, this is why it must not be used for sudden breathlessness or an asthma attack. You must not stop using budesonide suddenly after prolonged use, as the dose may need to be tapered before complete cessation.

Budesonide enters the cell and binds to glucocorticoid receptors present within the cell. This complex travels to the nucleus (the structure that contains DNA), where it stops pro-inflammatory genes, such as eosinophils, mast cells, and T-lymphocytes, and activates anti-inflammatory genes. This results in reduced immune cell activity at the site of inflammation, less tissue damage, and lower swelling, mucus production, and airway inflammation.

Formoterol targets a different site. It stimulates beta-2 adrenergic receptors on the smooth muscle surrounding the bronchial tubes. This causes the muscle to relax, widening the airway and allowing air to flow freely in and out of the lungs. The bronchodilator effect could start in 5 to 15 minutes and last up to 12 hours, providing sustained bronchodilation throughout the day.

• Always rinse your mouth and gargle with water after using a budesonide inhaler, as this would reduce the risk of oral candidiasis and hoarseness.

• Budesonide cannot stop a sudden asthma attack. This is why, one must carry their rescue inhaler separately.

• If you are switching from systemic corticosteroids to budesonide, do not stop your previous steroid abruptly. Follow your doctor's tapering plan to avoid adrenal crisis.

• Avoid grapefruit juice throughout your treatment, as it can substantially increase budesonide levels in the blood.

• If you have diabetes, monitor your blood glucose more closely after starting budesonide, especially oral formulations.

• In children receiving long-term inhaled budesonide, regular monitoring of height is recommended, as high doses may slow down growth.

Store Budesonide + Formoterol at room temperature between 20–25°C in a dry place away from direct environmental factors like sunlight, extreme heat, cold, and moisture. Do not freeze. Keep the inhaler away from open flames and sources of heat. If you use a nebuliser, store it in its original packaging away from light. Dispose of the MDI canister when the dose counter reads zero.

• Grapefruit and grapefruit juice (SEVERE): Grapefruit strongly inhibits CYP3A4 enzymes that break down budesonide in the gut wall and liver. This can increase budesonide blood levels significantly, increasing the risk of systemic steroid side effects.

• Alcohol (MODERATE): Alcohol can worsen the irritation in the airway and increase the risk of respiratory infections, thereby reducing the effectiveness of treatment. This is why, it is advised to limit or avoid alcohol consumption.

CYP3A4 inhibitors

SEVERE

Medications such as ketoconazole, itraconazole, ritonavir, and cobicistat are strong CYP3A4 inhibitors, an enzyme responsible for breaking down budesonide. This raises budesonide levels highly and increases the risk of systemic steroid toxicity, including adrenal suppression.

Other LABAs

SEVERE

Combining Formoterol with other LABAs, like salmeterol and arformoterol, may increase the risk of cardiovascular side effects such as increased heart rate, blood pressure, and arrhythmias.

Beta-blockers

SEVERE

Beta-blockers like metoprolol, atenolol & propranolol, can block the effect of Formoterol on the airway, potentially causing severe bronchoconstriction.

MAO inhibitors and tricyclic antidepressants

CAUTION

These medications, when taken along with Formoterol, can have cardiovascular effects, increasing the risk of arrhythmias.

CYP3A4 inducers

CAUTION

Medications like rifampicin, phenytoin, and carbamazepine speed up budesonide metabolism, thereby reducing its effectiveness.

Antidiabetics

CAUTION

Budesonide raises blood glucose, thus interfering with the action of antidiabetics like insulin, metformin, & sulfonylureas.

Diuretics

CAUTION

Diuretics like furosemide and thiazide can lower potassium levels, which can be worsened by Formoterol, resulting in hypokalemia.

Live vaccines

CAUTION

High-dose or prolonged corticosteroid therapy may impair immune response to live attenuated vaccines such as MMR and varicella.

Systemic Corticosteroids

CAUTION

When taken with systemic corticosteroids, budesonide may increase the overall steroid burden, raising the risk of adrenal suppression & Cushing's syndrome features.

• Heart disease or arrhythmia: Formoterol stimulates beta-2 adrenergic receptors, which can raise heart rate and blood pressure. This increases the risk for patients with pre-existing heart conditions, arrhythmias, or high blood pressure.

• Diabetes mellitus: Budesonide can raise blood glucose; this is why diabetics should monitor glucose levels more frequently when starting or changing doses.

• Active infections (TB, fungal, viral): Budesonide suppresses local immune responses and can worsen latent or active tuberculosis, systemic fungal infections, or serious viral infections. You must screen for TB before starting treatment.

• Osteoporosis: Prolonged corticosteroid use, even with local formulations, can reduce bone density.

• Liver disease: Impaired hepatic metabolism reduces first-pass clearance of budesonide, increasing systemic exposure.

• Glaucoma or cataracts: Prolonged corticosteroid use can raise intraocular pressure and may worsen glaucoma.

• Hypokalaemia (low potassium): Both formoterol and budesonide can reduce potassium levels in the blood. Therefore, people diagnosed with pre-existing low potassium or those on diuretics should get their potassium levels monitored regularly.

One small incident of Budesonide & Formoterol overdose may not result in a life-threatening emergency. However, it may lead to exaggerated side effects of both components, which may include tremors, palpitations, severe headache, rapid heart rate (tachycardia), low potassium levels, adrenal suppression or elevated blood glucose. Worth noting here is that prolonged overuse may cause symptoms of Cushing's syndrome and serious cardiac effects. If you suspect an overdose, stop using the medication and contact your doctor immediately.

If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular schedule. Never take a double dose to compensate for the missed one. Missing a single dose will not cause immediate harm, but irregular use reduces its efficacy.